<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>WORLD JOURNAL OF PLASTIC SURGERY</title>
<title_fa>مجله جهانی جراحی پلاستیک</title_fa>
<short_title>WJPS</short_title>
<subject>Medical Sciences</subject>
<web_url>http://wjps.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2228-7914</journal_id_issn>
<journal_id_issn_online>2252-0724</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.61882/wjps</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1405</year>
	<month>8</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2026</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<volume>15</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Evaluation of 30-Days Venous Thromboembolism (VTE) Following Autologous Breast Reconstruction</title>
	<subject_fa>تخصصي</subject_fa>
	<subject>Special</subject>
	<content_type_fa>مقالات اصيل</content_type_fa>
	<content_type>Original Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;span style=&quot;font-size:14px;&quot;&gt;&lt;span style=&quot;font-family:Times New Roman;&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Venous thromboembolism (VTE) is one of the known medical complications in autologous breast reconstruction (ABR) which is associated&amp;nbsp;&lt;br&gt;
with a short and long-term morbidity as well as mortality. Identifying VTE&amp;nbsp;&amp;nbsp;risk factors is crucial for appropriate VTE prophylaxis measurements to&amp;nbsp;&lt;br&gt;
lower this complication following ABR.&amp;nbsp;&lt;br&gt;
&lt;strong&gt;Methods:&lt;/strong&gt; Using American College of Surgeons National Surgery Quality Improvement Project database, we examined the clinical data of patients&amp;nbsp;&lt;br&gt;
who underwent ABR from 2016-2020 in the US. The frequency of VTE, day of occurrences and risk factors associated with VTE were evaluated.&amp;nbsp;&lt;br&gt;
&lt;strong&gt;Results&lt;/strong&gt;: Overall, 11,847 patients underwent ABR in the study period. The overall VTE rate was 1.0%. Totally 117 patients experienced VTE with a&amp;nbsp;&lt;br&gt;
total occurrence of 127. Postoperative day 1 and 2 were reported with the highest frequency of VTE (21/127). Using multivariate regression analysis,&amp;nbsp;&lt;br&gt;
independent risk factors associated with a higher VTE rate were length of hospital stay&gt;=5 d [adjusted odd&amp;rsquo;s ratio (AOR), 3.29], operative time&amp;nbsp;&lt;br&gt;
longer than 10 h (AOR,2.17), and immediate reconstruction (AOR,1.51). Although free flap breast reconstruction was associate with a higher VTE&amp;nbsp;&lt;br&gt;
rate compared with pedicled flap reconstruction (1.2% vs. 0.8%); however, multivariate regressing analysis did not show this factor as an independent&amp;nbsp;&lt;br&gt;
VTE risk factor.&lt;br&gt;
&lt;strong&gt;Conclusion:&lt;/strong&gt; Being proactive to make the patients ready to discharge by POD-4 and having strategy to shorten the length of operation could help to&amp;nbsp;&lt;br&gt;
lower the rate of VTE in ABR. Plastic surgeons should consider these factors and use appropriate prophylactic measures to minimize the risk of VTE&amp;nbsp;&lt;br&gt;
development.&lt;/span&gt;&lt;/span&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Risk factors, Venous thromboembolism, Autologous breast reconstruction</keyword>
	<start_page>0</start_page>
	<end_page>0</end_page>
	<web_url>http://wjps.ir/browse.php?a_code=A-10-477-6&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Hossein </first_name>
	<middle_name></middle_name>
	<last_name>Masoomi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>Hossein.Masoomi@kp.org</email>
	<code>100319475328460017419</code>
	<orcid>100319475328460017419</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Kaiser Permanente Bernard J. Tyson  School of Medicine, Pasadena,  California, United States</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Blake </first_name>
	<middle_name></middle_name>
	<last_name>P. Colton</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460017420</code>
	<orcid>100319475328460017420</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Kaiser Permanente Bernard J. Tyson  School of Medicine, Pasadena,  California, United States</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Erik </first_name>
	<middle_name></middle_name>
	<last_name>S. Marques</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460017421</code>
	<orcid>100319475328460017421</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Division of Plastic and Reconstructive  Surgery, University of Texas, Health  Science Center at Houston</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
